How Work Gets Done Here
Vira Health raised $12 million in a March 2022 Series A led by Octopus Ventures and Optum Ventures to turn a 12-week menopause app into a prescribing clinical service — telemedicine, pharmacy, U.S. expansion — on a team small enough that every hire changes how the work actually happens.
The company launched in 2020 from London with a £1.5 million seed round and a product called Stella: a guided 12-week program pairing symptom tracking with a personal coach. The Series A was explicitly raised to move beyond the app into prescribing, a regulatory and operational leap most femtech startups never attempt. Co-founder Andrea Berchowitz said she deliberately targeted funds with women's health track records, a signal that the cap table was chosen to reinforce the mission, not just finance it.
Vira Health operates as a tightly-knit, founder-led biotech startup where culture is shaped by direct access to leadership, high expectations for scientific rigor, and the constant pressure of a small team executing ambitious work. Decision-making sits close to the founders. Berchowitz has been the public voice on strategy, from the pivot to workplace benefits to the expansion roadmap, and the investor selection process suggests a leadership style that treats alignment as a prerequisite for capital. A clinical educator in Lithuania, a nurse practitioner in the U.S., and a product lead in London operate in the same reporting orbit.
The pace is set by the clinical roadmap. Stella's weekly "lesson unlock" cadence — new content, habit prompts, coach check-ins — creates a fixed rhythm the product and clinical teams must feed continuously. Add the B2B sales cycle into enterprise benefits platforms, and the feedback loop tightens: employer pilots demand measurable outcomes, which demand clinical rigor, which demands regulatory readiness.
Authority is functional, not hierarchical. The clinical educators own the localized patient experience across six European markets. No country manager layer exists; each educator reports into the clinical core. That structure only works if the clinical core sets unambiguous protocols and trusts the field to execute them. Berchowitz's pandemic-era framing, "everyone experiences healthcare differently," operates here as an operating principle: standardization stops at the protocol; the conversation adapts to the patient.
The pressure is structural. Women's health captures roughly 3 percent of digital health funding, per McKinsey and Rock Health, and female-only founding teams secured 1 percent of European VC in the last reported year. Vira Health is building in a $600 billion addressable market (per Female Founders Fund data) with a headcount that fits in a large conference room. The next section examines the values that team uses to decide what gets built, what gets cut, and who gets hired.
Values and Operating Principles
The job board tells a story the careers page doesn't. Vira Health's live postings on Zero G Talent — a Nurse Practitioner role for women's midlife health at $60–85 per hour, and five Clinical Educator positions across Belgian, Irish, Polish, Lithuanian, and French markets at $15–30 per hour — reveal a company building for clinical depth and geographic breadth simultaneously.
| Role | Hourly Range | Markets |
|---|---|---|
| Nurse Practitioner (Women's Midlife Health) | $60–85 | U.S. (UK registration required) |
| Clinical Educator | $15–30 | Belgium, Ireland, Poland, Lithuania, France |
That split reflects a founding principle Berchowitz has voiced: evidence-based care cannot scale without local clinical fluency. Berchowitz, a co-founder, has repeatedly framed Vira's mission around translating science into support that women actually use. The Nurse Practitioner role, listed as remote but requiring UK registration, carries that same logic: clinical authority sits above growth hacking. The median salaried compensation on the board, $62,000 across 13 roles, sits below London biotech benchmarks, suggesting the founding team optimizes for mission alignment over market-rate bidding wars.
The multilingual Clinical Educator cluster, five postings each for a single language market, operates on a different principle: trust before scale. Rather than launching a pan-European product with centralized support, Vira hires native-speaking clinicians per country. That model is slower, more expensive per user, and harder to manage. It also matches what Berchowitz has described: women in perimenopause don't want a chatbot; they want someone who understands their healthcare system, their language, and the cultural silence around this transition. The board data bears that out. Every educator role is remote, part-time, and hourly, structured for practicing clinicians who treat patients by day and guide Vira users by evening.
Vira doesn't publish a values deck. It hires clinicians who can defend the science. The board's salary band, the role mix, and the language-specific educator strategy are each a downstream consequence of that choice. Candidates who need structure, predictability, or a clear ladder will find none of it documented. What they will find is a team where the founders still review every clinical protocol, and where the next hire for the Lithuanian market matters as much as the next funding round.
The Hiring Bar
The hiring bar at Vira Health reflects a company that cannot afford passengers. With a small team building a regulated digital therapeutic for menopause — a condition most investors have never experienced — every hire needs to carry weight beyond their technical specification. The signals the founders select for read less like a competency framework and more like a survival checklist for a specific kind of startup: founder-led, capital-constrained, scientifically rigorous, and selling into a market the funding establishment barely understands.
Berchowitz has described the profile bluntly. The company actively recruits women in their 50s, the demographic its product serves, and treats their life stage as an asset, not a liability. In a 2022 Startups.co.uk interview she cited a 52-year-old employee, a mother of two, who moved from two days a week to full time and became "without a doubt the most ambitious person on our team. She is having this total second, third, fourth wave. She knows what she's good at and she is soaring." That example is not anecdotal color; it is a hiring thesis. Vira looks for what Berchowitz called "real expertise and lived experience": the compounding value of domain knowledge layered on top of professional skill. The company has argued against using "fast-paced" in job descriptions, framing the energy of mid-career professionals as "a huge wave of enthusiasm and excitement that comes at that point in someone's life and even better, it's on the back of like real expertise."
That preference shapes the current team. Recent openings cluster in clinical education and midlife health: all remote, all tied directly to the Stella product's clinical delivery and international rollout. These are not generic hires; they are specialists who can translate clinical protocol into patient-facing support across languages and regulatory regimes. The hiring signal is clear: you must understand the science, the patient, and the operational reality of delivering both at once.
Mission alignment functions as a filter because the fundraising environment demands it. Berchowitz described pitching "to a room full of men… trying to say, 'let me explain this thing to you that maybe you've never heard of.'" In 2021, just 1 percent of venture funding went to women founders, down from 2 percent the year before. Vira's team operates inside that bias. The founders have said the best defense is "to create a great product that people love," which means hiring people who treat scientific rigor and user trust as the same metric. Candidates who need external validation (press cycles, funding announcements, brand recognition) will not last. The company selects for stamina: "you've got to know you can get up tomorrow and do it all again… it has to be worth it to you. You have to really want to do it and it's got to be something you really believe in."
Diversity is not a program at Vira; it is a product requirement. Berchowitz has argued that "diverse teams create better solutions… more diversity means your product speaks to more people, which is commercially sound." The company hires across age, gender, and race because Stella must work for women whose symptoms, cultural contexts, and healthcare systems differ wildly. A Clinical Educator in Lithuania and a Nurse Practitioner in the U.S. are solving the same clinical problem under different constraints. The hiring bar rewards people who have navigated that kind of variance before: clinicians who have worked across systems, operators who have built in regulated environments without a playbook.
The through-line is discomfort tolerance. Vira's founders have described the daily reality of fundraising for a taboo topic, building clinical evidence in a neglected field, and managing a remote team across time zones with limited capital. They hire people who have already chosen difficult problems and kept working on them. The bar is not "can you do the job"; it is "will you still be pushing on it when the pattern recognition fails, the runway tightens, and the science gets harder?"
Who Thrives and Who Doesn't
The profile of someone who succeeds at Vira Health reads like the inverse of a traditional corporate hire. The company's board data shows a cluster of remote clinical educator roles across five European languages (French, Polish, Lithuanian, Irish, Belgian) alongside a U.S.-based nurse practitioner position focused on women's midlife health. That spread alone tells you the operation runs lean, distributed, and clinically grounded. The 13 salaried roles currently listed on the Zero G Talent board mean every hire carries operational weight from day one.
People who thrive here tend to share three traits. First, they operate comfortably without a playbook. The clinical educator roles require delivering patient education across different regulatory environments and languages. The job postings don't mention onboarding programs or dedicated localization support. Someone who needs a spec document before they move will stall. Second, they treat scientific rigor as a daily practice, not a checkpoint. The nurse practitioner role sits inside a product that makes clinical claims about menopause management. That means every patient interaction, every content decision, every feature prioritization gets measured against evidence standards. A candidate who views "clinical validation" as a milestone to clear before launch will frustrate the founders, who treat it as a continuous constraint. Third, they communicate upward without filtering. With direct access to leadership, the central reality of this culture, the signal-to-noise ratio depends on people surfacing bad news early. The board's salary band of $31k–$62k (median $62k) for salaried roles suggests a team that compensates fairly but expects outsized ownership per dollar.
Who struggles? Specialists who define their value by depth in a single domain and expect adjacent functions to handle the rest. A clinical educator who refuses to engage with product analytics because "that's not my job" creates a gap no one else will fill. Generalists who mistake breadth for competence also fail; the scientific bar is too high for dilettantes. The remote, multi-country structure punishes passive communicators; if you don't write clearly and respond promptly across time zones, the team moves without you. And anyone who conflates "founder-led" with "founder-pleasing" will misread the room. The pressure comes from the science and the patient, not the ego at the top. Candidates who optimize for visibility over validity get found out fast in a small company where every output is traceable.
The hiring signal isn't a credential checklist. It's whether you've operated in a constraint-heavy, evidence-driven, small-team environment before, and whether you want to do it again. The Lithuanian educator who spots a translation error in the clinical protocol at 11 p.m. her time, flags it in the shared channel, and watches the founder reply within minutes: that's the loop. It closes or it breaks. The people who stay are the ones who keep closing it.
Working in frontier tech? Zero G Talent tracks the openings: see every open Vira Health role, browse frontier tech jobs, the companies hiring, and the people building the field.